Filed: 5/7/2024ACC: 0000950123-24-003925
📋 What this filing means
SYNCONA PORTFOLIO LTD filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $150.05M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$150.05M
Total AUM (reported)
32.43M
Total Shares
Allocation by class
SPON ADS$136.19M90.8%
SPONSORED ADS$13.86M9.2%
Portfolio Concentration
Top 3$150.05M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 32.43M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
32.43M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other2
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings2
Rows:
AUTOLUS THERAPEUTICS PLC
OTRShares21.35M
TypeSH
Market value$136.19M
90.76%
Sole
0.00
Shared
21.35M
None
0.00
ACHILLES THERAPEUTICS PLC
OTRShares11.09M
TypeSH
Market value$13.86M
9.24%
Sole
0.00
Shared
11.09M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLCOTR | SPON ADS | 21.35M | SH | $136.19M 90.76% | 0.00 | 21.35M | 0.00 |
ACHILLES THERAPEUTICS PLCOTR | SPONSORED ADS | 11.09M | SH | $13.86M 9.24% | 0.00 | 11.09M | 0.00 |